Solaris Biotech

Solaris Biotech is a private, revenue-generating equipment and services provider for the global biomanufacturing industry. The company's core business is manufacturing integrated bioprocessing systems, including bioreactors, fermenters, and tangential flow filtration (TFF) systems, complemented by automation software (LEONARDO) and comprehensive engineering services from feasibility studies to turnkey plant construction. It serves a diverse international customer base across pharmaceuticals, agriculture, food & beverage, and industrial biochemistry, enabling the production of products like monoclonal antibodies, vaccines, biofertilizers, and plant-based foods. Solaris competes by offering scalable, configurable hardware and deep cross-industry expertise to support customers from concept to commercialization.

Integrated hardware, software, and service ecosystem for upstream and downstream bioprocessing. Includes scalable bioreactors/fermenters (200mL to 30,000L), tangential & full flow filtration systems, automation/control software (LEONARDO), and comprehensive engineering services (feasibility, basic engineering, turnkey solutions, revamping).

Solaris competes in a crowded market dominated by giants like Sartorius, Thermo Fisher Scientific, and Merck KGaA, who offer broad portfolios and global service networks. Its differentiation lies in high customization, a focus on stainless-steel fermentation, deep cross-industry application expertise, and an integrated service model from feasibility to turnkey plant delivery, often targeting niche applications and mid-market customers.